Enzo Biochem (ENZ)
0.6998 +0.0498 (+7.66%) 01/15/25 [NYSE]
0.6870 x 100 0.7500 x 4,000
Realtime by (Cboe BZX)
0.6870 x 100 0.7500 x 4,000
Realtime 0.7480 +0.0482 (-) 18:48 ET
for Wed, Jan 15th, 2025
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
07-2024 | 07-2023 | 07-2022 | 07-2021 | 07-2020 | |
Sales | 31,907 | 31,061 | 32,643 | 117,731 | 76,021 |
Cost of Goods | 17,275 | 19,495 | 19,213 | 64,154 | 52,251 |
Gross Profit | 14,632 | 11,566 | 13,430 | 53,577 | 23,770 |
Operating Expenses | 27,272 | 36,797 | 30,670 | 53,039 | 54,388 |
Operating Income | -12,365 | -24,736 | -17,027 | 692 | -30,367 |
Interest Expense | 197 | 1,399 | 0 | 0 | 0 |
Other Income | 2,745 | 1,113 | -3,312 | 7,183 | 1,847 |
Pre-tax Income | -9,817 | -25,022 | -20,339 | 7,875 | -28,520 |
Net Income Continuous | -9,817 | -25,022 | -20,339 | 7,875 | -28,520 |
Net Income Discontinuous | -16,261 | 45,310 | 2,078 | N/A | N/A |
Net Income | $-26,078 | $20,288 | $-18,261 | $7,875 | $-28,520 |
EPS Basic Total Ops | -0.51 | 0.41 | -0.38 | 0.16 | -0.60 |
EPS Basic Continuous Ops | -0.19 | -0.51 | -0.42 | 0.16 | -0.60 |
EPS Basic Discontinuous Ops | -0.32 | 0.92 | 0.04 | N/A | N/A |
EPS Diluted Total Ops | -0.51 | 0.41 | -0.38 | 0.16 | -0.60 |
EPS Diluted Continuous Ops | -0.19 | -0.51 | -0.42 | 0.16 | -0.60 |
EPS Diluted Discontinuous Ops | -0.32 | 0.92 | 0.04 | N/A | N/A |
EPS Diluted Before Non-Recurring Items | -0.19 | -0.51 | -0.23 | 0.21 | -0.51 |
EBITDA(a) | $-11,093 | $-22,054 | $-14,200 | $3,345 | $-27,587 |